[New antibacterial agents].
Vaara
M
M
HYKS-diagnostiikka PL 402, 00029 HYKS.
Saxén
H
H
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D017576:Daptomycin / Q000494:pharmacology / Q000627:therapeutic use; D024881:Drug Resistance, Bacterial; D004359:Drug Therapy, Combination / Q000494:pharmacology / Q000627:therapeutic use; D024841:Fluoroquinolones; D006801:Humans; D023303:Oxazolidinones / Q000494:pharmacology / Q000627:therapeutic use; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D014640:Vancomycin / Q000494:pharmacology / Q000627:therapeutic use; D014769:Virginiamycin / Q000494:pharmacology / Q000627:therapeutic use
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D023303:Oxazolidinones; D011500:Protein Synthesis Inhibitors; D014769:Virginiamycin; C062940:quinupristin-dalfopristin; C001202:evernimicin; D014640:Vancomycin; D017576:Daptomycin